StockData
Connect Biopharma Holdings Ltd logo

Connect Biopharma Holdings Ltd (CNTB) shareholders

CNTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.58−0.06 (-9.98%)

Close on Nov 17, 2026Market cap $36.45MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
22.1%
14M of 63M shares
Institutional holders
56
25 new, 10 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
2 buys · 0 sales
Net bought $4.37M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Panacea Innovation Limited
Joint filing with Panacea Venture Healthcare Fund II, L.P. (21.20%), Panacea Venture Healthcare Fund II GP Company, Ltd. (21.20%) and 1 more
13,160,00021.20%13D (active) amendmentMar 31, 2026
Wubin Pan
Joint filing with BioFortune Inc (9.50%)
6,026,8139.60%13G (passive)Apr 14, 2026
Zheng Wei5,015,9609.00%13G (passive) amendmentDec 31, 2025
Ikarian Capital, LLC
Joint filing with Neil Shahrestani (6.90%)
4,338,5346.90%13G (passive) amendmentJun 30, 2026
Braden M Leonard
Joint filing with BML Investment Partners, L.P. (6.10%)
4,264,4006.77%13G (passive)Sep 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of CNTBValueChange% of portfolio
Ikarian Capital, LLC4,538,5347.21%$10.80M−849,9521.16%
683 Capital Management, LLC1,285,0002.04%$3.06M+385,0000.15%
Boothbay Fund Management, LLC973,7321.55%$2.32M−260,8500.03%
BlackRock, Inc.871,6531.38%$2.07MNew0.00%
Perceptive Advisors LLC792,6961.26%$1.89M–0.03%
ADAR1 Capital Management, LLC700,0001.11%$1.67M−42,4000.08%
BML Capital Management, LLC573,2870.91%$1.36M+164,4000.78%
Silverarc Capital Management, LLC545,0000.87%$1.30MNew0.13%
Richmond Brothers, Inc.535,6120.85%$1.27M+59,0280.66%
Knott David M Jr444,8620.71%$1.06M+57,0270.56%
Stonepine Capital Management, LLC364,2540.58%$866.93K+54,2540.49%
Marshall Wace, Llp335,6420.53%$798.83K+269,6290.00%
Geode Capital Management, LLC257,4540.41%$612.74K+225,3250.00%
Two Sigma Investments, LP199,3810.32%$474.53K+151,9160.00%
Diadema Partners LP196,9850.31%$468.82K−3,7050.06%
Burkehill Global Management, LP150,0000.24%$357.00K–0.01%
Vanguard Portfolio Management LLC102,7550.16%$244.56KNew0.00%
Susquehanna International Group, Llp102,1480.16%$243.11K−176,6600.00%
Renaissance Technologies LLC87,3000.14%$207.77K−33,4000.00%
Northern Trust Corp82,8620.13%$197.21KNew0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 20265614M22.1%25 / 159 / 103M2M
Q1 20264113M20.2%15 / 97 / 35M0M
Q4 2025298M13.4%15 / 55 / 28M1M
Q3 2025162M2.6%5 / 43 / 60M1M
Q2 2025172M3.9%6 / 23 / 10M1M
Q1 2025133M4.5%1 / 14 / 20M0M
Q4 2024143M5.1%5 / 22 / 20M0M
Q3 2024113M4.7%2 / 31 / 20M0M
Q2 2024123M4.7%2 / 14 / 20M1M
Q1 2024124M6.3%2 / 14 / 50M3M
Q4 2023157M11.3%4 / 36 / 32M5M
Q3 20231410M16.0%1 / 32 / 30M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Barry D. QuartChief Executive Officer, Director224,0340.36%Mar 16, 2026
Lisa PerazaSenior Vice President, Finance45,1890.07%Mar 16, 2026
David Leslie SzekeresPresident215,7390.34%Mar 16, 2026
Jean I. LiuDirector20,7630.03%Oct 1, 2026
Kleanthis Gabriel XanthopoulosDirector91,5540.15%Oct 1, 2026
James HuangDirector13,310,00021.14%Jun 2, 2026
James A. SchoeneckDirector––Mar 16, 2026
Karen J. WilsonDirector10,0000.02%Mar 16, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Kleanthis Gabriel Xanthopoulos
Director
Sep 30, 2026Award+5,000––91,554
Jean I. Liu
Director
Sep 30, 2026Award+8,984––20,763
Kleanthis Gabriel Xanthopoulos
Director
Jun 30, 2026Award+3,738––86,554
Jean I. Liu
Director
Jun 30, 2026Award+6,718––11,779
James Huang
Director
May 29, 2026Buy+150,000$2.48$372.00K13,310,000
Kleanthis Gabriel Xanthopoulos
Director
Mar 31, 2026Award+2,816––82,816
Jean I. Liu
Director
Mar 31, 2026Award+5,061––5,061
James Huang
Director
Mar 31, 2026Buy+1,160,000$3.45$4.00M13,160,000

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
4M shares short
Days to cover
4.2
At 1M shares a day
Change since last report
-0.7%
From 4M shares
Short volume, 20 days
50.2%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Connect Biopharma's stock actually held short. Settlement fails (shares not delivered on time) peaked at 510,315 shares on Oct 1, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Panacea Innovation Limited
10% Owner
Nov 24, 20252,000,000$6.00MNov 24, 2025The Ordinary Shares were purchased in multiple open market transactions from 2022 through September 2025.
Wei Zheng
10% Stockholder
Nov 21, 2025650,000$2.07MNov 21, 2025Compensation- Stock Award
BioFortune Inc
10% Stockholder
Nov 18, 2025500,000$1.25MNov 18, 2025Acquired under Employee Incentive Plan as employee of the Securities Issuer
Wei Zheng
10% Stockholder
Oct 1, 2025200,000$305.94KOct 1, 2025Compensation- Stock Award
Wei Zheng
10% Stockholder
Jun 11, 202539,775$32.22KJun 11, 2025Compensation-Stock Award
RA Capital Healthcare Fund LP
10% Stockholder
Dec 18, 20231,765,788$1.67MDec 18, 2023IPO Investment
RA Capital Nexus Fund, L.P.
10% Stockholder
Dec 18, 2023295,650$279.03KDec 18, 2023Open Market Purchase
RA Capital Nexus Fund, L.P.
10% Stockholder
Dec 12, 202336,959$33.26KDec 12, 2023Open Market Purchase
RA Capital Healthcare Fund LP
10% Stockholder
Dec 12, 2023220,738$198.66KDec 12, 2023Open Market Purchase
RA Capital Nexus Fund, L.P.
10% Stockholder
Nov 27, 2023151,778$195.79KNov 27, 2023IPO Investment
RA Capital Healthcare Fund LP
10% Stockholder
Nov 27, 2023906,504$1.17MNov 27, 2023Open market purchase
RA Capital Healthcare Fund LP
10% Stockholder
Nov 21, 2023471,732$971.77KNov 21, 2023IPO Investment
RA Capital Nexus Fund, L.P.
10% Stockholder
Nov 21, 202378,983$162.70KNov 21, 2023IPO Purchase

See a number that looks wrong?